Turning Medical Insights into Patient Impact
Veeva research reveals a stark gap between the insights biopharma captures and the actions it takes – highlighting a missed opportunity to improve patient outcomes
False
Advertisement
Related Content
Small Molecules
Development & Clinical
Small Molecules
Musings from The Power List: Peng Lu
September 4, 2026
2 min read
Peng Lu argues that small molecules remain indispensable as AI transforms drug development
Future of Pharma
Future of Pharma
Business & Trends
What Will Drug Development Look Like in 2036?
September 3, 2026
7 min read
Members of The Medicine Maker’s 2026 Power List predict how AI, new modalities, integrated data, and shifting global markets will reshape the industry
Biopharma
Biopharma
Regulation & Standards
China’s Biopharma Homecoming
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han
Biopharma
Biopharma
Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics
August 31, 2026
4 min read
New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products